Literature DB >> 9097306

Severe myopia as a risk factor for progressive visual field loss in primary open-angle glaucoma.

E Chihara1, X Liu, J Dong, Y Takashima, M Akimoto, M Hangai, S Kuriyama, H Tanihara, M Hosoda, S Tsukahara.   

Abstract

The optic nerve head in severely myopic eyes may be particularly vulnerable to glaucomatous damage. To study this hypothesis, we examined 122 primary open-angle glaucoma eyes with fair to good control of the intraocular pressure and a sign of baseline optic nerve damage. Then, parameters for the progression of the visual field defects were evaluated by multivariate analysis. A high mean intraocular pressure (p = 0.007) and a large refractive error (p = 0.023) were significant risk factors for subsequent visual field loss. A high baseline cup-to-disk ratio (p = 0.100) was a marginal risk factor. Nonsignificant parameters included patient age (p = 0.692), the use of beta-adrenergic antagonists (p = 0.384), gender (p = 0.831) and left versus right side (p = 0.977). When the refractive error was used to subclassify patients into severely myopic (< or = -4 dpt), mildly myopic (-0.25 to -4 dpt), or emmetropic and hyperopic (> or = 0 dpt), only severe myopia was a significant risk factor for progressive visual field loss. Severe myopia, but not mild myopia, is a significant risk factor for subsequent visual field loss in patients with primary open-angle glaucoma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9097306     DOI: 10.1159/000310760

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  43 in total

1.  Scanning laser polarimetry in myopic and hyperopic subjects.

Authors:  Stephan Kremmer; Thomas Zadow; Klaus-Peter Steuhl; J Michael Selbach
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-03-17       Impact factor: 3.117

2.  Different types of optic disc shape in patients with advanced open-angle glaucoma.

Authors:  Toru Nakazawa; Nobuo Fuse; Kazuko Omodaka; Naoko Aizawa; Souichiro Kuwahara; Kohji Nishida
Journal:  Jpn J Ophthalmol       Date:  2010-08-11       Impact factor: 2.447

3.  Refractive error, ocular and general parameters and ophthalmic diseases. The Beijing Eye Study.

Authors:  Liang Xu; Qi Sheng You; Jost B Jonas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-11-24       Impact factor: 3.117

4.  The bugeye mutant zebrafish exhibits visual deficits that arise with the onset of an enlarged eye phenotype.

Authors:  Joseph M Stujenske; John E Dowling; Farida Emran
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-13       Impact factor: 4.799

5.  Optic disc tilt direction affects regional visual field progression rates in myopic eyes with open-angle glaucoma.

Authors:  Jong Rak Lee; Jiyun Lee; Jong-Eun Lee; Jin Young Lee; Michael S Kook
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-06       Impact factor: 3.117

6.  Lamina cribrosa thickness is not correlated with central corneal thickness or axial length in healthy eyes: central corneal thickness, axial length, and lamina cribrosa thickness.

Authors:  Eun Ji Lee; Tae-Woo Kim; Robert N Weinreb; Min Hee Suh; Hyunjoong Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-09-20       Impact factor: 3.117

7.  Association between myopia and glaucoma in the United States population.

Authors:  Mary Qiu; Sophia Y Wang; Kuldev Singh; Shan C Lin
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-28       Impact factor: 4.799

8.  Scanning laser polarimetry in normal subjects and patients with myopia.

Authors:  S C Ozdek; M Onol; G Gürelik; B Hasanreisoglu
Journal:  Br J Ophthalmol       Date:  2000-03       Impact factor: 4.638

9.  [Glaucoma and ocular hypertension in primary care].

Authors:  J Jaén Díaz; I Sanz Alcolea; F López De Castro; T Pérez Martínez; P Ortega Campos; R Corral Morales
Journal:  Aten Primaria       Date:  2001-06-15       Impact factor: 1.137

Review 10.  [Myopia and glaucoma].

Authors:  Christoph Faschinger; Georg Mossböck
Journal:  Wien Med Wochenschr       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.